A Retrospective Cohort Study to Assess Predicted Rate and Associated Factors of Dabigatran-induced Bleeding Events in Patients with Non-Valvular Atrial Fibrillation.
Phase of Trial: Phase IV
Latest Information Update: 31 Jul 2018
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Atrial fibrillation
- Focus Adverse reactions
- 31 Jul 2018 New trial record